Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swiss sell-off

This article was originally published in The Gray Sheet

Executive Summary

Jomed could declare bankruptcy by April 2, when creditors will vote whether to make the company's preliminary suspension of debt payments final, as advised by Jomed administrators, the firm tells investors March 13. Meanwhile, the company is "intensifying the efforts of divesting certain assets," following completion of a deal with Edwards Lifesciences, involving Jomed's catheter-based heart valve repair technology (1"The Gray Sheet" Feb. 24, 2003, p. 15). By end of trading March 13, Jomed shares dropped $0.84, or 30%, to $2.02...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT018059

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel